id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-1687-0002,FDA,FDA-2013-N-1687,"Advisory Committee; Pharmacy Compounding Advisory Committee,
Renewal",Notice,Notice of Renewal,2016-05-06T04:00:00Z,2016,5,2016-05-06T04:00:00Z,,2016-05-06T14:04:19Z,2016-10585,0,0,0900006481fb0d56
FDA-2013-N-1687-0001,FDA,FDA-2013-N-1687,Advisory Committee; Pharmacy Compounding Advisory Committee,Rule,Final Rule,2014-01-13T05:00:00Z,2014,1,2014-01-13T05:00:00Z,,2014-01-13T15:04:44Z,2014-00322,0,0,090000648150369e